Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Neuromodulation : Journal of the International Neuromodulation Society
|
October 14, 2011
Successful peripheral nerve field stimulation for thoracic radiculitis following Brown-Sequard syndrome
Mehul J Desai, Mehul Desai, Lisa Jacob, et al.
British Journal of Clinical Pharmacology
|
June 20, 2003
Variability of heart rate correction methods for the QT interval
Mehul Desai, Lang Li, Zeruesenay Desta, et al.
Medical Mycology Case Reports
|
September 12, 2019
Multiple organ dysfunction syndrome and death secondary to <i>Cyberlindnera fabianii</i>
Mehul Desai, Bradley Nitta, Hussain Dhanani, et al.
JAMA
|
June 16, 2005
Safety of ximelagatran
Allen Brinker, Ruyi He, Mehul Desai, et al.
PDA Journal of Pharmaceutical Science and Technology
|
June 16, 2025
Economic Advantages of Original Container Closure Systems in Combination Product Development: Scenarios with Expert Validation and Industry-Quantified Cost-Time Savings
Mehul Desai, Daniel Waites, William Rich, et al.
Drug Delivery
|
April 3, 2025
Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study
Mehul Desai, Beth Faiman, Lisa A Gorski, et al.
Drug Delivery
|
July 29, 2025
Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'
Mehul Desai, Beth Faiman, Lisa A Gorski, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
February 11, 2017
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Michael J Davies, Katherine W Merton, Ujjwala Vijapurkar, et al.
Current Medical Research and Opinion
|
December 16, 2016
Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis
Rong Qiu, Dainius Balis, John Xie, et al.
Journal of the American Society of Nephrology : JASN
|
August 20, 2016
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects
Hiddo J L Heerspink, Mehul Desai, Meg Jardine, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Neuromodulation : Journal of the International Neuromodulation Society
|
October 14, 2011
Successful peripheral nerve field stimulation for thoracic radiculitis following Brown-Sequard syndrome
Mehul J Desai, Mehul Desai, Lisa Jacob, et al.
British Journal of Clinical Pharmacology
|
June 20, 2003
Variability of heart rate correction methods for the QT interval
Mehul Desai, Lang Li, Zeruesenay Desta, et al.
Medical Mycology Case Reports
|
September 12, 2019
Multiple organ dysfunction syndrome and death secondary to <i>Cyberlindnera fabianii</i>
Mehul Desai, Bradley Nitta, Hussain Dhanani, et al.
JAMA
|
June 16, 2005
Safety of ximelagatran
Allen Brinker, Ruyi He, Mehul Desai, et al.
PDA Journal of Pharmaceutical Science and Technology
|
June 16, 2025
Economic Advantages of Original Container Closure Systems in Combination Product Development: Scenarios with Expert Validation and Industry-Quantified Cost-Time Savings
Mehul Desai, Daniel Waites, William Rich, et al.
Drug Delivery
|
April 3, 2025
Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study
Mehul Desai, Beth Faiman, Lisa A Gorski, et al.
Drug Delivery
|
July 29, 2025
Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'
Mehul Desai, Beth Faiman, Lisa A Gorski, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
February 11, 2017
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Michael J Davies, Katherine W Merton, Ujjwala Vijapurkar, et al.
Current Medical Research and Opinion
|
December 16, 2016
Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis
Rong Qiu, Dainius Balis, John Xie, et al.
Journal of the American Society of Nephrology : JASN
|
August 20, 2016
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects
Hiddo J L Heerspink, Mehul Desai, Meg Jardine, et al.
Page
of 9